Jaguar Health, Inc.
JAGXNASDAQHealthcare● Active
$2.73
$-0.07(-2.50%)
Market Cap$181927
P/E Ratio—
52W High$144.55
52W Low$2.53
Jaguar Health, Inc. (JAGX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · JAGX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $11.51M | $11.69M | $9.76M | $11.96M | $4.33M |
| Cost of Revenue | $3.77M | $1.96M | $2.04M | $2.02M | $2.33M |
| Gross Profit | $7.74M | $9.73M | $7.72M | $9.94M | $2.00M |
| Gross Margin %(computed) | 67.21% | 83.27% | 79.13% | 83.11% | 46.18% |
| Operating Expenses | |||||
| R&D Expenses | $24.97M | $16.54M | $18.60M | $17.65M | $15.08M |
| G&A Expenses | $18.64M | $16.33M | $16.59M | $17.87M | $17.10M |
| Total Operating Expenses | $53.65M | $40.56M | $42.02M | $44.35M | $42.71M |
| Operating Income | ($45.91M) | ($30.83M) | ($34.29M) | ($34.41M) | ($40.71M) |
| Operating Margin %(computed) | -398.82% | -263.76% | -351.31% | -287.85% | -939.05% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $8.42M |
| Interest Expense | ($0.07M) | $0.23M | $6.38M | $12.72M | $8.42M |
| Income Before Tax | ($54.00M) | ($39.25M) | ($41.90M) | ($48.40M) | ($52.60M) |
| Income Tax Expense | ($0.42M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($53.58M) | ($38.49M) | ($41.30M) | ($47.45M) | ($52.59M) |
| Net Margin %(computed) | -465.42% | -329.30% | -423.11% | -396.91% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-803.95 | $-4574.07 | $-93992.00 | $-1899528.00 | $-4631759.00 |
| Wtd Avg Shares | 0.07M | 0.01M | 0.00M | 0.00M | 0.00M |
| EBITDA | ($45.91M) | ($36.66M) | ($32.76M) | ($33.38M) | ($42.37M) |
| EBITDA Margin %(computed) | -398.82% | -313.65% | -335.62% | -279.19% | -977.30% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Jaguar Health, Inc. data
About Jaguar Health, Inc. (JAGX) Income Statement
Jaguar Health, Inc. (JAGX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, JAGX reported revenue of $0.01B, gross profit of $0.01B (gross margin 67.21%), and net income of ($0.05B) — a net profit margin of -465.42%.
Frequently asked questions
JAGX · 4 questionsJaguar Health, Inc. (JAGX) reported revenue of $0.01B for 2025, down 1.5% year-over-year.
JAGX revenueJAGX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08